ArticleCancer medicine2021

MiR-362 suppresses cervical cancer progression via directly targeting BAP31 and activating TGFβ/Smad pathway.

Shuya Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.